ArticleAnimals : an open access journal from MDPI2025
Dog Guardian Interpretation of Familiar Dog Aggression Questions in the C-BARQ: Do We Need to Redefine "Familiar"?
Article in Animals : an open access journal from MDPI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The C-BARQ familiar dog aggression (FDA) subscale contains four items relating to threatening responses towards familiar dogs in the same household (i.e., dog rivalry). In a recent study, we noticed that 92 of 157 guardians who owned only one dog completed the FDA items, generating an unexpected score. We followed up with participants to explore whether lifestyle factors influenced their completion of the FDA items. Singleton dogs with FDA scores were more likely to regularly participate in social activities with other dogs, with many scores based on such interactions with non-household dogs. The singleton dogs with FDA scores also had marginally lower fear-related C-BARQ scores compared to singletons with no FDA score and dogs living in multi-dog households. We then conducted a scoping review of articles using English versions of the C-BARQ and found wide variation in whether or not FDA scores were reported. Studies that reported significant FDA findings often did not indicate the proportion of scores in their data that came from singleton dogs, raising issues of accuracy and interpretation of the subscale. We discuss ways to clarify the interpretation of the FDA questions by dog guardians and hope to promote further consideration of practices to improve replicability across studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.